|
1. Conventional Research Grants
|
|
Dr. Ignacio Anegon
INSERM U643, ITERT, Nantes, France
|
Heme Oxygenase-1 promotes Tolerogenic Dendritic Cells: Analysis of Mechanisms and in vivo Applications
|
Dr. Robert Colvin
Massachusetts General Hospital, Boston, USA
|
Mechanisms of Antibody-Mediated Chronic Rejection in Mouse Cardiac and Kidney Allografts
|
Dr. Christiane Ferran
Beth Israel Deaconess Medical Center, Boston, USA
|
Role of A20 upon Homing of EC and SMC Progenitors to Lesions of Transplant Arteriosclerosis
|
Dr. Peter Heeger
The Cleveland Clinic, Cleveland, USA
|
Complement Proteins regulate the Immune Responses that cause Transplant Rejection
|
Dr. Régis Josien
INSERM U643, ITERT, Nantes, France
|
The Role of Plasmacytoid Dendritic Cells in the Expansion and Function of CD4+CD25+ Regulatory T Cells
|
Dr. Daniel Kreisel
Washington University in St. Louis, St. Louis, USA
|
The Role of Vascular Endothelium in Regulating Immune Responses
|
Dr. Qizhi Tang
UCSF Diabetes Center, San Francisco, USA
|
Visualizing Regulatory T Cell Control of Islet Transplant Rejection
|
Dr. Anne M. VanBuskirk
Ohio State University, Columbus, USA
|
Cytokine Interactions in Post-Transplant Lymphoproliferative Disorder (PTLD)
|
|
2. Clinical Research Grants
|
|
Dr. Henderikus G. Otten
University Medical Centre Utrecht, Utrecht, The Netherlands
|
Prediction of Chronic Rejection which is the Main Cause of Long-Term Mortality after Lung Transplantation
|
Dr. Allan Ramirez
Emory University, Atlanta, USA
|
Peroxisome Proliferator-Activated Receptor Gamma in Obliterative Bronchiolitis
|
